Credit Suisse’s Precision BioSciences DTIL Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q1 | – | Sell |
-1,261
| Closed | -$45K | – | 3373 |
|
2022
Q4 | $45K | Buy |
+1,261
| New | +$45K | ﹤0.01% | 3400 |
|
2022
Q3 | – | Sell |
-1
| Closed | – | – | 4075 |
|
2022
Q2 | $0 | Sell |
1
-1,039
| -100% | – | ﹤0.01% | 3998 |
|
2022
Q1 | $95K | Buy |
1,040
+69
| +7% | +$6.3K | ﹤0.01% | 3463 |
|
2021
Q4 | $216K | Buy |
971
+42
| +5% | +$9.34K | ﹤0.01% | 3416 |
|
2021
Q3 | $321K | Buy |
929
+221
| +31% | +$76.4K | ﹤0.01% | 3230 |
|
2021
Q2 | $265K | Sell |
708
-359
| -34% | -$134K | ﹤0.01% | 3327 |
|
2021
Q1 | $332K | Sell |
1,067
-1,390
| -57% | -$433K | ﹤0.01% | 3129 |
|
2020
Q4 | $614K | Buy |
2,457
+1,809
| +279% | +$452K | ﹤0.01% | 2875 |
|
2020
Q3 | $119K | Buy |
648
+204
| +46% | +$37.5K | ﹤0.01% | 3157 |
|
2020
Q2 | $111K | Buy |
+444
| New | +$111K | ﹤0.01% | 3183 |
|